antibody Latest News

A new report by Visiongain shows that next-generation technologies will become a major driver for the antibody therapeutics market.

CHI’s 4th Annual Cancer Biologics, February 13-15, 2013, San Francisco, CA

Phase I funding of the competitive grant is to develop a novel commercial assay to measure host HIV antibody avidity ("binding ability"), an indicator of antibody maturation, which can be used to determine recent vs. long-term HIV-1 infections.

tebu-bio is proud to announce that they have been awarded the designation of Certified Service Provider (CSP) of RayBiotech’s antibody array testing services.

Monoclonal antibody still belongs to high-end products in Chinese market, mainly depending on imports.

New pre-clinical and clinical data on Mentrik Biotech’s ocaratuzumab, a humanized, next-generation anti-CD20 monoclonal antibody for treatment of follicular lymphoma, was released in Clinical Cancer Research, published by the AACR.

David Woodward, Senior Director of Biological Sciences at Allergan and Barbara Wirostko, Chief Medical Officer at Altheos will give a joint featured presentation at the 4th Ocular Diseases and Drug Discovery Conference

Engineering Next-Generation Therapeutic Proteins: Trends and Markets To 2020 Report

NuGel™ Poly-Amine for affinity purification of interleukin enhancer binding factor 3 (Ilf3) and nuclear factor 90 (NF90) interactome

A new report by Visiongain shows that next-generation technologies will become a major driver for the antibody therapeutics market.

CHI’s 4th Annual Cancer Biologics, February 13-15, 2013, San Francisco, CA

The New Generation of Antibody Therapeutics: Current Status and Future Prospects

Phase I funding of the competitive grant is to develop a novel commercial assay to measure host HIV antibody avidity ("binding ability"), an indicator of antibody maturation, which can be used to determine recent vs. long-term HIV-1 infections.

tebu-bio is proud to announce that they have been awarded the designation of Certified Service Provider (CSP) of RayBiotech’s antibody array testing services.

Monoclonal antibody still belongs to high-end products in Chinese market, mainly depending on imports.

Those that missed last month's event can get a CD with 80 speaker presentations from 4 pipelines: formulation, purification, biotherapeutics, and expression. Individual track CDs and the overall event CD is available at CHI-PepTalk.com.

New pre-clinical and clinical data on Mentrik Biotech’s ocaratuzumab, a humanized, next-generation anti-CD20 monoclonal antibody for treatment of follicular lymphoma, was released in Clinical Cancer Research, published by the AACR.

David Woodward, Senior Director of Biological Sciences at Allergan and Barbara Wirostko, Chief Medical Officer at Altheos will give a joint featured presentation at the 4th Ocular Diseases and Drug Discovery Conference

A new report by Visiongain predicts that overall revenues for monoclonal antibody (mAb) therapies will rise between 2011 and 2021. The world mAb drugs market will reach $62.3bn in 2015, up from revenues of $44.6bn (USD) in 2010.

Engineering Next-Generation Therapeutic Proteins: Trends and Markets To 2020 Report

Desmogleins are members of the desmosomal cadherins that provide adhesive integrity to desmosomes between adjoining keratinocytes. Desmoglein 3 is autoantigen of the autoimmune disease pemphigus vulgaris, and plays role in squamous cell cancer.

Leveraging proven technology from Eurogentec, AnaSpec's parent company, this protocol uses a proprietary mixture of Freund's free immuno-stimulatory compounds.

AnaSpec, Eurogentec Group is pleased to offer anti-5-methylcytidine (Clone 33D3), Eurogentec’s most popular monoclonal antibody, for use in epigenetics research.

RayBiotech, Inc., announced today it will renew its Biomarker Discovery Pilot Grant program for 2011 and will accept applications for restricted pilot grants of $5,000 to $20,000 worth of RayBiotech products and/or services beginning in early 2011.

Since the launch of their first mini-website dedicated to SilenciX, tebu-bio has subsequently released sites focussed on Preadipocytes and Antibody Arrays, with the most recent addition now centered around CryostaX™.

Therapeutic protein and antibody engineering expert Dr. Mark Liddament appointed Research Manager at OBodies

Bharatbook added a new report on "Antibody Technology Companies 2010" into its market report catalogue for reselling.

According to our new research report 'Global Monoclonal Antibody Market Analysis', the global monoclonal antibodies market witnessed an annual growth rate of around 13% during 2008-2009.

IBC USA - Antibody Engineering - Register today

OctoChem Inc. has announced a new services solution that gives the Life Sciences manufacturer the alternative distribution channel it needs with the complete control and visibility it deserves.

RayBiotech, Inc., a leading developer and supplier of multiplex protein and antibody arrays, was recently awarded an STTR research grant to identify protein markers that could potentially be used in a diagnostic test for endometriosis.

Randox Life Sciences is a recognised primary manufacturer of high quality, cost effective monoclonal antibodies to both classic and novel targets.

RayBiotech announced the recipients of its Biomarker Discovery Grants. By sponsoring these awards, RayBiotech intends to demonstrate that any researcher with a modest research budget can discover disease-related biomarkers using its antibody arrays.

Recently published research from Business Insights, "Preclinical Development of Monoclonal Antibodies and Related Biologicals: Emerging technologies and new therapeutic candidates", is now available at Fast Market Research

Generally custom antibody development takes more time for process but with the launch of new four phase protocol it can be possible to produce antibodies in just four weeks and is capable of managing 500-1000 BALB/c mice and nude mice.

Novus Biologicals, an international supplier of antibodies, biological products and materials to various scientific sectors, announce that they have launched the first TMEM97 antibody onto the market.

Isogenica and the Defence Science and Technology Laboratory develop antimicrobial peptide drugs with potential to treat MRSA

Novus Biologicals, an international supplier of antibodies, biological products and materials to various scientific sectors

Novus Biologicals, an international supplier of antibodies, biological products and materials to various scientific sectors, have launched new Histone antibodies for use in DNA repair research.

Isogenica and Phylogica target peptide drugs for inflammatory disease

Novus Biologicals, an international supplier of antibodies, biological products and materials to various scientific sectors, have launched a new HIF Prolyl Hydroxylase antibody for use in research

A study in the December issue of Nature Cell Biology identified a potential drug target for breast cancer. RayBiotech Antibody Arrays were vital to this discovery, including one detecting phosphorylation of EGFR family receptors at multiple sites.

Cambridge, England - Novus Biologicals, an international supplier of antibodies, biological products and materials to various scientific sectors, have announced the opening of a new validation facility at their headquarters.

Novus Biologicals, an international supplier of antibodies, biological products and materials to various scientific sectors, is proud to announce the opening of their first European office in Cambridge, England.

RayBiotech today announced the establishment of its Biomarker Discovery Pilot Grant program, consisting of restricted grants of $10,000 to $20,000 worth of RayBiotech products and services for protein biomarker discovery.

Monoclonal antibody-based therapies for cancer are a thriving part of the biotechnology sector, as our new market report explains.

GenScript will sponsor the BIT Life Sciences’ 1st Annual International Congress of Antibodies (ICA). CEO Dr. Frank Zhang will give keynote speech to share thoughts on antibody drug development.

GenScript offers high quality bundled bio-reagent samples to appreciate customers and assist in biology research under current tough economic condition.

GenScript raises the quality standard for its antibody packages.

Conference to be held at 22nd - 23rd January 2009, BSG Conference Centre, London, UK

IRI Separation Technologies (TSX.V:IRI) is the manufacturer of a remarkable new dietary supplement that enhances the human body’s natural immune system through direct supplementation of actual antibodies.

Lee Biosolutions’ extensive human donor program allows them to process over 500 liters of human saliva per year for their human salivary amylase production requirements for IVD manufacturers and clinical researchers.

Lee Biosolutions, Inc. announces the increased production and availability of the highest purity affinity purified polyclonal Ferritin antibodies and native human ferritin antigens to the clinical research community and IVD manufacturers.